BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 6813503)

  • 1. Protein SAP (serum amyloid P-component) in Waldenström's macroglobulinaemia, multiple myeloma and rheumatic diseases.
    Strachan AF; Johnson PM
    J Clin Lab Immunol; 1982 Sep; 8(3):153-6. PubMed ID: 6813503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
    Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
    Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of blood viscosity in rheumatic diseases].
    Roques CF; Amigues H; Fournie A; Simon J; Guiraud R
    Nouv Presse Med; 1977 Sep; 6(30):2686. PubMed ID: 409995
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunoglobulin levels in the serum of patients with myeloma and Waldenström's macroglobulinemia].
    Linz R; Lecocq E
    C R Seances Soc Biol Fil; 1971; 165(5):1191-4. PubMed ID: 4261510
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum protein immunofixation in malignant hemopathies other than multiple myeloma and Waldenstrom's macroglobulinemia].
    Ramont L; Ngoc PT; Pignon B; Maquart FX
    Ann Biol Clin (Paris); 2002; 60(5):565-70. PubMed ID: 12368142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amyloidosis. II. Current pathogenetic and clinico-nosographic aspects].
    Lovisetto P; Frascisco M; Gilardi E; Marchi L; Mairano D
    Minerva Med; 1980 Jun; 71(25):1801-13. PubMed ID: 6774298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute phase proteins in monoclonal gammapathies].
    Dubost JJ; Ristori JM; Soubrier M; Ruivard M; Sauvezie B
    Pathol Biol (Paris); 1991 Oct; 39(8):769-73. PubMed ID: 1722302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inflammatory rheumatism and Waldenström's macroglobulinemia].
    Welfling J
    Rev Rhum Mal Osteoartic; 1974 Oct; 41(10):573-7. PubMed ID: 4218655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urine light chain levels in benign monoclonal gammapathies, multiple myeloma and Waldenström's macroglobulinaemia.
    Dammacco F; Waldenström J
    Clin Exp Immunol; 1968 Nov; 3(9):911-21. PubMed ID: 4180117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyacrylamide electrophoresis. II. Study of serum proteins in multiple myeloma and Waldenstrom's macroglobulinemia.
    Dammacco F; Pinto L
    Riv Ist Sieroter Ital; 1967; 42(1):17-23. PubMed ID: 4970260
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum anti-lipid A antibodies in multiple myeloma and Waldenström's macroglobulinaemia.
    Fink PC; Galanos C
    Immunobiology; 1985 Feb; 169(1):1-10. PubMed ID: 3921455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal immunoglobulinaemia in rheumatological practice.
    Trnavský K; Cebecauer L; Zbojanová M; Hajzok O
    Czech Med; 1979; 2(3):116-24. PubMed ID: 119619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uric acid levels of the serum of healthy persons and patients with various rheumatic diseases].
    Bośmanský K; Ondrasík M
    Ter Arkh; 1987; 59(4):22-5. PubMed ID: 3495897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major microheterogeneity of alpha 1-acid glycoprotein in management of patients with rheumatic diseases.
    Mackiewicz A; Pawłowski T
    Prog Clin Biol Res; 1989; 300():219-22. PubMed ID: 2789388
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusually large (83 amino acid residues) amyloid fibril protein AA from a patient with Waldenström's macroglobulinaemia and amyloidosis.
    Møyner K; Sletten K; Husby G; Natvig JB
    Scand J Immunol; 1980; 11(5):549-54. PubMed ID: 6155694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?
    Bladé J; Montoto S; Rosiñol L; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):329-31. PubMed ID: 12720163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the amyloid A protein (AA protein) and a related serum component-purification-partial characterization and tissue origin and distribution in different types of amyloidosis.
    Franklin EC; Rosenthal CJ; Pras M
    Adv Nephrol Necker Hosp; 1975; 5():89-97. PubMed ID: 811096
    [No Abstract]   [Full Text] [Related]  

  • 19. [The blood coagulation system in patients with Waldenstrom's macroglobulinemia and multiple myeloma].
    Kokeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1968 Jun; 13(6):10-5. PubMed ID: 4981865
    [No Abstract]   [Full Text] [Related]  

  • 20. [Amyloidosis: an immunoproliferative disease].
    Lovisetto P; Ricci C; Marchi L; Biarese V
    Recenti Prog Med; 1973 Sep; 55(3):229-48. PubMed ID: 4203558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.